Halozyme Therapeutics
HALO
#2478
Rank
S$7.79 B
Marketcap
$61.29
Share price
-15.40%
Change (1 day)
15.13%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.63 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$0.94 Billion. In 2023 the company made an earning of S$0.46 Billion, an increase over its 2022 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.63 B35.65%
2023 S$0.46 B39.94%
2022 S$0.33 B0.16%
2021 S$0.33 B92.2%
2020 S$0.17 B-278.96%
2019 -S$97.01 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$82.71 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$43.28 Million-52.86%
2014 -S$91.81 Million-18.09%
2013 -S$0.12 Billion55.88%
2012 -S$71.91 Million169.94%
2011 -S$26.64 Million-63.44%
2010 -S$72.85 Million-7.19%
2009 -S$78.49 Million15.91%
2008 -S$67.72 Million83.89%
2007 -S$36.83 Million78.1%
2006 -S$20.68 Million16%
2005 -S$17.83 Million45.24%
2004 -S$12.28 Million682.42%
2003 -S$1.57 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$18.64 M-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.62 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.11 Billion-115.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.63 Billion-352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.94 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
S$24.69 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA